CrossPoint Therapeutics
Latest round
- Seed
Last raised
- Apr 2024
Total raised
- $1.6M
Investors
- 4
About CrossPoint Therapeutics
Based in Hwaseong, South Korea, and founded in 2022 by CEO Tae-Erk Kim, CrossPoint Therapeutics operates as a provider of dual-target immuno-oncology drugs and antibody-drug conjugate therapies that use its stealth-body platform technology to treat refractory diseases. The company provides a wide range of biotechnological solutions, such as protein delivery CPP-001, small molecule delivery CPS-001, and gene delivery CPR-001, with the help of Stealth-Body technology. Additionally, the firm offers research and development services in smart cell targeting.
Who invested in CrossPoint Therapeutics
4 investors across 1 round
See all investors in CrossPoint Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 1, 2024
Amount
$1.6M
Investors
Questions about CrossPoint Therapeutics
Who invested in CrossPoint Therapeutics?
CrossPoint Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CrossPoint Therapeutics raised?
CrossPoint Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CrossPoint Therapeutics last raise money?
CrossPoint Therapeutics's most recent round on record is a Seed, in Apr 2024.
What does CrossPoint Therapeutics do?
Based in Hwaseong, South Korea, and founded in 2022 by CEO Tae-Erk Kim, CrossPoint Therapeutics operates as a provider of dual-target immuno-oncology drugs and antibody-drug conjugate therapies that use its stealth-body platform technology to treat refractory diseases.
Where is CrossPoint Therapeutics headquartered?
CrossPoint Therapeutics is headquartered in Hwaseong, South Korea.
Which VCs invest in companies like CrossPoint Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at CrossPoint Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like CrossPoint Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.